Identifying blood biomarkers for obstructive sleep apnea using microRNAs
Official title: MicroRNAs as Biomarkers for Obstructive Sleep Apnea
Run by University of Pennsylvania · NCT06189755 · Data updated 2026-11-12
This study is testing if certain blood markers can help identify obstructive sleep apnea in people by looking at tiny molecules called microRNAs.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | University of Pennsylvania Academic / other |
| Locations | 3 sites (Columbus, Ohio and 2 other locations) |
| Status | Recruiting |
| Started | April 1, 2024 |
| Main results expected | November 1, 2027 |
| Study ends | April 30, 2028 |
| Registry record updated | August 3, 2026 |
| Trial ID | NCT06189755 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18-75 with moderate to severe obstructive sleep apnea who are willing to accept positive airway pressure therapy.
✕Probably not a fit
Patients currently using positive airway pressure therapy or with certain medical conditions, such as chronic kidney disease requiring dialysis, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to develop and validate blood biomarkers specific to obstructive sleep apnea (OSA) by analyzing microRNAs. The research will compare microRNA profiles between individuals with moderate to severe OSA and healthy controls matched for age, sex, and body mass index. The study will utilize sequencing techniques and quantitative PCR to assess microRNA expression, which may help improve case identification, monitor therapy efficacy, and predict blood pressure responses to treatment. By establishing these biomarkers, the study seeks to enhance the management of OSA patients.
Why it matters
Potential benefit: If successful, this study could lead to improved identification and management of obstructive sleep apnea through the use of specific blood biomarkers.
How similar studies have gone: Previous studies have suggested differences in microRNA expression between OSA cases and controls, indicating potential success for this novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria for Cases: * age 18-75 years * moderate-severe OSA (defined as AHI ≥15 events/hour) * willing to accept PAP therapy Inclusion Criteria for Controls: * age 18-75 years * no OSA (defined as AHI \<5 events/hour) Exclusion Criteria for Cases: * current use of PAP or other OSA treatments * home oxygen therapy * recent changes (within 3 months) to BP medications among those who are on these medications * presence of Cheyne-Stokes Respiration (CSR) in sleep study * predominantly central sleep apnea (AHI≥15 events/hour, with \>50% central events) * pregnancy * clinical history of chronic kidney disease (Stage 5) requiring dialysis, or renal transplant * organ transplantation * self-reported sleep duration less than 5 hours per night on weeknights (work nights) * current night shift work Exclusion Criteria for Controls: * home oxygen therapy * pregnancy * clinical history of chronic kidney disease (Stage 5) requiring dialysis, or renal transplant * organ transplantation * self-reported sleep duration less than 5 hours per night on weeknights (work nights) * current night shift work
Where it's running
-
The Ohio State University - Martha Morehouse Medical Pavilion, Suite 2600
Columbus, Ohio, United States Recruiting -
University of Pennsylvania
Philadelphia, Pennsylvania, United States Recruiting -
University of Iceland
Reykjavik, Iceland Recruiting
Study contacts
- Principal investigator: Allan I Pack, MBChB, PhD — University of Pennsylvania
- Study coordinator: Colleen M Walsh, MS
- Email: walshco@pennmedicine.upenn.edu
- Phone: 215-614-0047
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Multimodal Deep Learning to Predict Sleep Apnea Severity from SpO2 and Ballistocardiography
Researchers are testing a smart-mattress-based method that uses SpO2 and ballistocardiography data to predict sleep apnea severity in adults undergoing overnight sleep study.
-
Nightly wearable monitoring with at-home submental electrical stimulation for sleep apnea
This pilot test checks whether wearing a ring sensor at night and doing a 4-week at-home submental electrical stimulation is feasible for adults with obstructive sleep apnea and looks at changes in sleep metrics.
-
Functional capacity and muscle function in adults with obstructive sleep apnea
This study tests how obstructive sleep apnea affects respiratory and peripheral muscle strength, endurance, and upper‑extremity function compared with healthy adults.
-
Transcutaneous Electrical Stimulation for Obstructive Sleep Apnea
This study tests whether applying gentle electrical stimulation to the throat muscles at night can reduce sleep apnea severity in adults with obstructive sleep apnea.
-
Physical activity habits and sleep/ breathing in obstructive sleep apnea
This study tests whether daily physical activity habits affect sleep quality and breathing measurements in people with obstructive sleep apnea who are on CPAP therapy.
-
CES-EES score and a wearable ring for diagnosing obstructive sleep apnea
This study tests whether the CES-EES clinical score and the Belun Ring wearable can accurately diagnose obstructive sleep apnea without in-lab polysomnography in adults referred for suspected OSA.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.